Treatment with low doses of tranylcypromine resulted in a disappointing remission rate [1]

American Journal of Psychiatry

Volumn 164, Issue 3, 2007, Pages 524-

  Nolen, Willem A ^a   Van Den Broek, Walter W ^a   Birkenhäger, Tom K ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMIPRAMINE; MIRTAZAPINE; PHENELZINE; TRANYLCYPROMINE; VENLAFAXINE;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEPRESSION; DOSE RESPONSE; DRUG MEGADOSE; ELECTROCONVULSIVE THERAPY; HUMAN; INTERMETHOD COMPARISON; LETTER; LOW DRUG DOSE; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT PLANNING; TREATMENT RESPONSE;

EID: 34047143210     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.2007.164.3.524     Document Type: Letter

References (4)

1. McGrath PJ, Stewart JW, Fava M, Trivedi MH, Wisniewski SR, Nierenberg AA, Thase ME, Davis L, Biggs MM, Shores-Wilson K, Luther JF, Niederehe G, Warden D, Rush AJ, STAR*D Study Team: Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report. Am J Psychiatry 2006; 163:1531-1541
2. Nolen WA, Van de Putte JJ, Dijken WA, Kamp JS, Blansjaar BA, Kramer HJ, Haffmans J: Treatment strategy in depression II: MAO inhibitors in depression resistant to cyclic antidepressants: two controlled crossover studies with tranylcypromine versus L-5-hydroxytryptophan and nomifensine. Acta Psychiatr Scand 1988; 78:676-683
3. Birkenhäger TK, Van den Broek WW, Mulder PG, Bruijn JA, Moleman P: Efficacy and tolerability of tranylcypromine versus phenelzine: a double-blind study in antidepressant-refractory depressed inpatients. J Clin Psychiatry 2004; 65:1505-1510
4. Medical Research Council Clinical Psychiatry Committee: Medical Research Council trial of the treatment of depressive illness. BMJ 1965; 1:881-886